SAT-300 EFFECTS OF DAPAGLIFLOZIN AND DAPAGLIFLOZIN PLUS SAXAGLIPTIN ON HbA1c AND ALBUMINURIA IN PATIENTS WITH TYPE 2 DIABETES AND CHRONIC KIDNEY DISEASE: PHASE II/III DELIGHT STUDY
Pollock, C., Wheeler, D.C., Rossing, P., Sjostrom, D., Stefansson, B., Reyner, D., Langkilde, A.M., Heerspink, H.J.Volume:
4
Language:
english
Journal:
Kidney International Reports
DOI:
10.1016/j.ekir.2019.05.340
Date:
July, 2019
File:
PDF, 190 KB
english, 2019